Nevertheless, our data combined both p16INK4a immunostaining and the p16 FISH quantitative results and demonstrated a clinically very useful scheme for detection of urothelial carcinoma of the bladder by p16 gene expression in urine cytology specimens. The gene discussed is CDKN2A; the disease is bladder transitional cell carcinoma.